Conversely, miR-222, miR-127, miR-197, and miR-223 target C-X-C motif chemokine ligand 12 (CXCL12) and other associated genes, decreasing proliferation and impairing the tumor immune response in lung cancer, further enhancing dormancy [87]. This evidence concerns the gene CXCL12 and lung cancer.